Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. It is selective against all the other isozymes (1000-fold) except HDAC8 (57-fold).

Panobinostat, a cinnamic hydroxamic acid analogue, is a novel broad-spectrum inhibitor of HDAC with potential antineoplastic activity.

Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.

Quercetin is a polyphenolic flavonoid with potential chemopreventive activity.

Apabetalone (RVX-208), a potent BET bromodomain inhibitor,  has been investigated for the treatment of Diabetes, Atherosclerosis, and Coronary Artery Disease.

Curcumin is a natural component of the rhizome of turmeric. Its biological effects range from antioxidant, anti-inflammatory to inhibition of angiogenesis and is also shown to possess specific antitumoral activity.

Decitabine is a cytidine antimetabolite analogue with potential antineoplastic activity.

Divalproex Sodium is a stable coordination compound comprised of sodium valproate and valproic acid with anticonvulsant and antiepileptic activities.